Yahoo Web Search

Sign In

  1. Also Try

Search results

  1. www.astrazeneca.com › media-centre › press-releasesLynparza and Imfinzi combination recommended for approval in the...

    2 days ago · Lynparza is the foundation of AstraZeneca’s industry-leading portfolio of potential new medicines targeting DDR mechanisms in cancer cells. AstraZeneca in immuno-oncology (IO) AstraZeneca is a pioneer in introducing the concept of immunotherapy into dedicated clinical areas of high unmet medical need.

    • Careers

      A.Catalyst Network is an interconnected and dynamic global...

    • Investor Relations

      Investor Relations - Lynparza and Imfinzi combination...

    • What science can do

      What science can do - Lynparza and Imfinzi combination...

    • R&D

      R&D - Lynparza and Imfinzi combination recommended for...

    • Our therapy areas

      CVRM (Cardiovascular, Renal and Metabolism) is one of our...

    • Our company

      At AstraZeneca, sustainability is part of our DNA, embedded...

  2. www.astrazeneca.com.au › news › media-releasesFIRST TARGETED TREATMENT FOR SEVERE SYSTEMIC LUPUS ERYTHEMATOSUS...

    2 days ago · The PBS reimbursement of SAPHNELO® is for the treatment of severe systemic lupus erythematosus (SLE) with high disease activity, despite standard of care. This is the first time a targeted treatment for severe SLE has been reimbursed on the PBS. Lupus is a disease in which the immune system attacks its own cells and tissues, causing ...

  3. www.reuters.com › business › healthcare-pharmaceuticalsAstraZeneca's COVID prevention drug application gets EU...

    2 days ago · AstraZeneca said on Monday that the European Union drug regulator has accepted a market authorisation application for its investigational COVID-19 prevention drug, sipavibart, for an accelerated ...

  4. www.ukri.org › who-we-are › how-we-are-doingThe story behind the Oxford-AstraZeneca COVID-19 vaccine success

    1 day ago · Based on all the available evidence from clinical trials and real world use, we know that two doses of the Oxford AstraZeneca vaccine are effective at reducing COVID-19 infections. They have also prevented thousands of hospitalisations and deaths, even against the more infectious Delta variant. It’s been a huge privilege to be part of a ...

  5. www.reuters.com › markets › companiesAZN.L - | Stock Price & Latest News | Reuters

    5 days ago · Get AstraZeneca PLC (AZN.L) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.

    • 73M

  6. markets.ft.com › data › equitiesAstraZeneca PLC, AZN:LSE summary - FT.com - Financial Times

    5 days ago · Latest AstraZeneca PLC (AZN:LSE) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

  7. finance.yahoo.com › news › astrazeneca-azn-imfinzi-combo-getsAstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for Expanded Use

    1 day ago · AstraZeneca AZN announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of its PD-L1 inhibitor Imfinzi (durvalumab ...

  8. Images

    • AstraZeneca
    • astrazeneca-logo-png-1280-1280x512 - Fluidda : Fluidda

    View all

  1. Searches related to AstraZeneca

    AstraZeneca vaccine
    AstraZeneca singapore pte ltd
    AstraZeneca share price
    AstraZeneca singapore
    bayer
    AstraZeneca yahoo finance
    AstraZeneca side effects
    AstraZeneca china
  2. People also search for